1. IGF-1 Gene Transfer to Human Synovial MSCs Promotes Their Chondrogenic Differentiation Potential without Induction of the Hypertrophic Phenotype
- Author
-
Ryota Chijimatsu, Yasutoshi Ikeda, Tomoyuki Suzuki, David A. Hart, Morito Sakaue, Toshihiko Yamashita, Hideki Yoshikawa, Hidenori Otsubo, Henning Madry, Kazunori Shimomura, and Norimasa Nakamura
- Subjects
0301 basic medicine ,lcsh:Internal medicine ,Pathology ,medicine.medical_specialty ,Article Subject ,0206 medical engineering ,02 engineering and technology ,Biology ,Viral vector ,Glycosaminoglycan ,03 medical and health sciences ,Gene expression ,medicine ,lcsh:RC31-1245 ,Molecular Biology ,Hyaline cartilage ,Cartilage ,Mesenchymal stem cell ,Cell Biology ,Chondrogenesis ,020601 biomedical engineering ,Phenotype ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,Research Article - Abstract
Mesenchymal stem cell- (MSC-) based therapy is a promising treatment for cartilage. However, repair tissue in general fails to regenerate an original hyaline-like tissue. In this study, we focused on increasing the expression levels for insulin-like growth factor-1 (IGF-1) to improve repair tissue quality. The IGF-1 gene was introduced into human synovial MSCs with a lentiviral vector and examined the levels of gene expression and morphological status of MSCs under chondrogenic differentiation condition using pellet cultures. The size of the pellets derived from IGF-1-MSCs were significantly larger than those of the control group. The abundance of glycosaminoglycan (GAG) was also significantly higher in the IGF-1-MSC group. The histology of the IGF-1-induced pellets demonstrated similarities to hyaline cartilage without exhibiting features of a hypertrophic chondrocyte phenotype. Expression levels for the Col2A1 gene and protein were significantly higher in the IGF-1 pellets than in the control pellets, but expression levels for Col10, MMP-13, ALP, and Osterix were not higher. Thus, IGF-1 gene transfer to human synovial MSCs led to an improved chondrogenic differentiation capacity without the detectable induction of a hypertrophic or osteogenic phenotype.
- Published
- 2017
- Full Text
- View/download PDF